Published on September 11, 2009 at 5:49 AM
Reportlinker.com announces that a new market research report is available in its catalogue: US and European Radiopharmaceuticals Market
http://www.reportlinker.com/p0109914/US-and-European-Radiopharmaceuticals-Market.html
This report analyzes the US and the European markets for Radiopharmaceuticals in Millions of US$. The major product segments analyzed are Diagnostic Radiopharmaceuticals, and Therapeutic Radiopharmaceuticals. Annual forecasts are provided for each region for the period of 2006 through 2015. A six-year historic analysis is also provided for these markets with annual market analytics. The report profiles 82 companies including many key and niche players such as Actinium Pharmaceuticals, Inc., Advanced Medical Isotope Corporation, Alseres Pharmaceuticals, Inc., Bayer HealthCare Pharmaceuticals, Bio-Nucleonics, Inc., Bracco Diagnostics, Inc., Cardinal Health, Inc., Cellectar, LLC., Cell Therapeutics, Inc., Covidien Imaging Solutions, Cytogen Corporation, Draximage Inc, GE Healthcare Limited, GlaxoSmithKline Plc, IBA Molecular North America, Inc., Immunomedics, Inc., Kimberly-Clark, Inc., Lantheus Medical Imaging, Inc, MDS Nordion, Molecular Insight Pharmaceuticals, Inc., Peregrine Pharmaceuticals, Inc., PETNET Pharmaceuticals, Inc., Pharmalucence, Inc., and Triad Isotopes, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Source: http://www.reportlinker.com
728d86bc-f9d3-4654-8d1f-3d309fa76664|0|.0
Posted in: Pharmaceutical News
Tags: Antibody, Bone, Brain, Brain Cancer, Cancer, Cardiology, Cell, Ciprofloxacin, Diagnostics, Epilepsy, Follicular Lymphoma, Hyperthyroidism, Lymphoma, Medicare, Neurology, Nuclear Medicine, Oncology, Radiation Exposure, Radiation Therapy, Radiology, Radiotherapy, Thyroid Cancer, Zevalin